ArticleChinese medical journal2025

Precision therapy targeting CAMK2 to overcome resistance to EGFR inhibitors in FAT1 -mutated oral squamous cell carcinoma.

Yumeng Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.